Drug Type Small molecule drug |
Synonyms- |
Target |
Action antagonists |
Mechanism P2RX2 antagonists(purinergic receptor P2X 2 antagonists), P2X3 receptor antagonists(P2X purinoceptor 3 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Cardiovascular Diseases | Discovery | - | 26 Jun 2024 | |
| Immune System Diseases | Discovery | - | 26 Jun 2024 | |
| Neoplasms | Discovery | - | 26 Jun 2024 | |
| Other Diseases | Discovery | - | 26 Jun 2024 | |
| Pruritus | Discovery | - | 26 Jun 2024 | |
| Respiration Disorders | Discovery | - | 26 Jun 2024 | |
| Urogenital Diseases | Discovery | - | 26 Jun 2024 | |
| Virus Diseases | Discovery | - | 26 Jun 2024 |





